BVMF/RDOR3 (BVMF/RDOR3)

Brazil Stock Exchange: BVMF/RDOR3 · BRL

R$32.3

-1.43 (-4.2%)· Recorded snapshot

Market cap	70.3B
Revenue (ttm)	57.8B
Net income (ttm)	4.8B
EPS (ttm)	R$2.20
Shares out	2.2B
P/E (trailing)	14.7x
P/E (forward)	14.2x
Dividend	R$4.29 (13.31%)
Volume	9,063,500
Beta	0.62

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.8B
Net income (ttm): 4.8B
EPS (ttm): R$2.20
P/E (trailing): 14.7x
P/E (forward): 14.2x
Market cap: 70.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E14.2

P25 n/aP50 n/aP75 n/a

Trailing P/E14.7

P25 n/aP50 n/aP75 n/a

ROE19.8

P25 n/aP50 n/aP75 n/a

ROIC23.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/RDOR3 indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

BRL

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-11
Employees	31,400
Enterprise value	BRL 86.7B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1977
Industry	Medical Care Facilities
Is primary listing	Yes
ISIN number	BRRDORACNOR8
Last earnings date	2026-08-12
Last refreshed	2026-10-29
Market cap	BRL 70.3B
Next earnings date	2026-11-11
Price	BRL 32.26
Price currency	BRL
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-29
Symbol	bvmf/RDOR3
Website	https://www.rededorsaoluiz.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	13.43x
Average P/E ratio (3Y)	21.07x
Average P/E ratio (5Y)	35.6x
Earnings yield	6.82%
EV/Earnings	18.62x
EV/EBIT	8.04x
EV/EBITDA	6.89x
EV/Sales	1.55x
FCF / EV yield	-4.62%
FCF yield	-5.65%
Forward P/E	14.17x
Graham number	21.6912
Graham upside	-35.62%
Lynch fair value	BRL 54.97
Lynch upside	63.17%
P/B ratio	3.2x
P/E ratio	14.67x
P/S ratio	1.27x
PEG ratio	0.82x
Price / tangible book value	14.48x
Price/EBITDA ratio	5.83x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.26%
EBITDA margin	21.8%
Effective tax rate	22.66%
Gross margin	23.07%
Operating margin	19.26%
Pretax margin	11.25%
Profit margin	8.34%
Profit per employee	BRL 153,586
Profitable quarters	24
Profitable years	13
Revenue per employee	BRL 1.8M
ROA	6.35%
ROA (5Y)	4.54%
ROCE	11.9%
ROE	19.78%
ROE (5Y)	12.63%
ROIC	23.67%
ROIC (5Y)	15.85%
SBC / revenue	0.14%
Tax / revenue	2.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	17.71%
EPS growth (Q)	22.89%
EPS growth (QoQ)	26.93%
EPS growth 10Y	7.55%
EPS growth 3Y	62.21%
EPS growth 5Y	25.81%
EPS growth quarters	1
EPS growth years	3
FCF growth (Q)	821.15%
Gross profit growth	27.27%
Gross profit growth (Q)	22.15%
Gross profit growth 3Y	28.69%
Gross profit growth 5Y	24.72%
Net income growth	17.26%
Net income growth (Q)	20.7%
Net income growth (QoQ)	24.98%
Net income growth 3Y	57.47%
Net income growth 5Y	27.45%
Net income growth quarters	1
Net income growth years	3
OCF growth (Q)	85.75%
OCF growth (QoQ)	186.48%
Operating income growth	35.34%
Operating income growth (Q)	23.7%
Operating income growth 3Y	34.26%
Operating income growth 5Y	26.14%
Revenue growth	9.44%
Revenue growth (Q)	5%
Revenue growth (QoQ)	2.21%
Revenue growth 10Y	22.99%
Revenue growth 3Y	18.56%
Revenue growth 5Y	26.4%
Revenue growth quarters	24
Revenue growth years	12

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -3.2B
Depreciation and amortization	BRL 1.5B
EBIT	BRL 11.1B
EBITDA	BRL 12.6B
EPS	BRL 2.20
FCF per share	BRL -1.90
Financing cash flow	BRL 3.6B
Free cash flow	BRL -4.1B
Free cash flow minus SBC	BRL -4.2B
Gross profit	BRL 13.3B
Income taxes	BRL 1.5B
Investing cash flow	BRL -4.7B
Net borrowing	BRL 12.5B
Net cash flow	BRL -2.1B
Net income	BRL 4.8B
Operating cash flow minus SBC	BRL -983.9M
Operating income	BRL 11.1B
Revenue	BRL 57.8B
Stock-based compensation	BRL 80.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.83
Book value per share	BRL 9.51
Debt / EBITDA	4.43
Debt / equity	2.51
Goodwill	BRL 12.5B
Interest coverage	1.78
Long-term assets	BRL 55.9B
Long-term liabilities	BRL 70.6B
Net cash (debt)	BRL -14.1B
Net cash / market cap	-19.25%
Net debt / EBITDA	1.12
Net debt / equity	0.62
Piotroski F-Score	5
Property, plant and equipment	BRL 21B
Shareholders' equity	BRL 22.9B
Tangible book value	BRL 5.1B
Tangible book value per share	BRL 2.33
Total assets	BRL 113.2B
Total cash	BRL 43.3B
Total debt	BRL 57.5B
Total liabilities	BRL 90.3B
WACC	7.97%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	BRL 57.3B
Current liabilities	BRL 19.7B
Current ratio	2.91
Inventory turnover	40.32
Net working capital	BRL -1.5B
Quick ratio	2.79
Working capital	BRL 37.6B
Working capital turnover	1.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.39%
Dividend growth	432.95%
Dividend growth (3Y)	153.98%
Dividend growth years	2
Dividend payment date	2026-10-06
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	BRL 4.29
Dividend yield	13.31%
Ex-dividend date	2026-09-25
Last dividend	BRL 0.18
Payout ratio	145.54%
Shareholder yield	13.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 36.71
1D price change	-4.24%
1M price change	-14.06%
1M total return	-14.06%
1W price change	-26.33%
1W total return	-26.33%
1Y price change	-24.41%
1Y return CAGR	-16.29%
1Y total return	-16.28%
20-day SMA	BRL 41.53
200-day SMA	BRL 37.74
3M price change	-6.18%
3M total return	-5.72%
3Y price change	45.37%
3Y return CAGR	19.07%
3Y total return	68.85%
50-day SMA	BRL 38.60
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 48.41
52-week high date	2025-11-10
52-week low	BRL 30.50
52-week low date	2026-10-26
5Y price change	-45.88%
5Y return CAGR	-8.46%
5Y total return	-35.73%
6M price change	-16.21%
6M total return	-15.35%
All-time high	BRL 77.30
All-time high date	2021-08-24
All-time low	BRL 19.35
All-time low date	2023-03-28
Average true range (ATR)	BRL 2.14
Average volume	12.4M
Beta (1Y)	0.25
Beta (2Y)	0.36
Beta (5Y)	0.62
Change from 52-week high	-33.36%
Change from 52-week low	5.77%
Change from all-time high	-58.34%
Change from all-time low	66.41%
Change from open	-3.79%
Day's gap	-0.47%
Dollar volume	BRL 292.4M
High price	BRL 34.00
Low price	BRL 31.99
Monthly RSI	44.98
Open price	BRL 33.53
Position in 52-week range	13.43%
Previous close	BRL 33.69
Price vs 150-day SMA	-12.29%
Price vs 20-day SMA	-22.47%
Price vs 200-day SMA	-14.67%
Price vs 50-day SMA	-16.58%
Relative volume	0.73
RSI	25.74
Sharpe ratio	-0.31
Sharpe ratio (3Y)	0.55
Sharpe ratio (5Y)	-0.19
Sortino ratio	-0.27
Sortino ratio (3Y)	0.96
Sortino ratio (5Y)	-0.12
Volume	9.1M
Weekly RSI	40.61
YTD price change	-20.71%
YTD total return	-19.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.1B
Shares change (QoQ)	-1.54%
Shares change (YoY)	-0.39%
Shares held by insiders	34.48%
Shares held by institutions	32.15%
Shares outstanding	2.2B

Deeper analysis on BVMF/RDOR3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/RDOR3 report

Is a complete BVMF/RDOR3 research report available?

No complete published report is available for bvmf/RDOR3 (BVMF/RDOR3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/RDOR3 (BVMF/RDOR3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/RDOR3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/RDOR3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/RDOR3

Frequently asked questions